BSESupha Pharmachem LtdMediumNeutral
Announced Fri, 31 Oct · 21:56 IST

the Board in ite metting approved 1. Appointed Mr. Rambhajan Vishwakarma . 2. Appointed Mr. Vignesh Laxman Gawde . 3. Approved the Postal Ballot notices 4. The Board has reconstituted ....

Director Flagged GovernanceMultiple Ind Directors ResignedManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board, at its meeting on October 31, 2025, appointed Mr. Rambhajan Vishwakarma as an Additional Non-Executive Non-Independent Director and Chairman, and Mr. Vignesh Laxman Gawde as Whole Time Director for 5 years at a remuneration of Rs. 50,000 per month. A Postal Ballot was approved to seek shareholder consent for three items: changing the company's name, regularising Mr. Vishwakarma's chairmanship, and approving Mr. Gawde's appointment and pay. All four board committees (Audit, NRC, Stakeholders' Relationship, and Risk Management) were reconstituted following the changes. Notably, the Nomination and Remuneration Committee had been dissolved due to resignations of its director-members, so NRC recommendations for these appointments could not be obtained. The signed letter says 'For Remedium Lifecare Limited,' suggesting the name change discussed in the postal ballot may be further along than just proposed. Shareholders will vote electronically between November 8 and December 7, 2025.

Likely market impact

Shareholders will vote on a company name change and two director appointments over the coming weeks. The dissolved NRC and inability to obtain its recommendation raise governance concerns that investors should monitor closely.